Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma

P. Van Schil

Source: Breathe 2005; 2: 173
Journal Issue: December
Disease area: Thoracic oncology

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Van Schil. Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma. Breathe 2005; 2: 173

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 755s
Year: 2007

Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Malignant pleural mesothelioma: our multimodality approach
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002

Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009


Multimodality therapy for malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Appropriateness between UICC and IMIG staging systems in management of malignant pleural mesothelioma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003

The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Thoracoscopy and malignant pleural mesothelioma
Source: ERS Course 2015
Year: 2015

68Ga-DOTA-NT-20.3. An innovative probe for neurotensin receptor-positive tumor imaging in the diagnosis of malignant pleural mesothelioma
Source: International Congress 2018 – Pleural disease: diagnosis, monitoring and management
Year: 2018




Multimodal therapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Guideline 2020
Year: 2020

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019
Year: 2020



Telomerase activity as additional diagnostic tool in pleural malignant effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

PET predicts survival in malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=290
Year: 2007

Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015